WG
RVMD icon

Winton Group’s Revolution Medicines RVMD Stock Holding History

Winton Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,838
Closed -$762K – 1451
2026
Q1 		$762K Sell
7,838
-4,945
-39% -$499K 0.03% 605
2025
Q4 		$1.02M Buy
+12,783
New +$838K 0.04% 475
2021
Q4 		– Sell
-10,350
Closed -$285K – 1340
2021
Q3 		$285K Sell
10,350
-5,350
-34% -$156K 0.02% 1121
2021
Q2 		$498K Buy
15,700
+3,927
+33% +$137K 0.03% 922
2021
Q1 		$540K Buy
11,773
+4,719
+67% +$212K 0.03% 842
2020
Q4 		$279K Buy
+7,054
New +$279K 0.02% 1073

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Winton Group's RVMD Position: Q2 2026 in Review

Winton Group sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 7,838 shares — an estimated $762K sold.

Winton Group first reported a position in RVMD in Q4 2020 and held it in 6 quarters. The position peaked at $1.02M in Q4 2025. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Winton Group reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Winton Group sold 7,838 Revolution Medicines shares in Q2 2026, an estimated $762K.
  • Winton Group first reported a position in Revolution Medicines in Q4 2020 and held it in 6 quarters.
  • Winton Group's Revolution Medicines position peaked at $1.02M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.